Agneta Siegbahn

15.0k citations
131 papers · 6.0k indexed · 2 hit papers · h-index 39

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Acute Myocardial Infarction Research
    • Cardiac Arrhythmias and Treatments

Papers in

    • Venous Thromboembolism Diagnosis and Management 19
    • Atrial Fibrillation Management and Outcomes 45
    • Antiplatelet Therapy and Cardiovascular Diseases 28
    • Acute Myocardial Infarction Research 21
    • Cardiac Fibrosis and Remodeling 11

Agneta Siegbahn

127 papers receiving 5.9k citations

Hit Papers

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study 2016 · 330 citations
3302016202620192022100200300

Peers

Agneta Siegbahn
Comparison fields: 5 of 139
  • Internal Medicine 1.2k
  • Cardiology and Cardiovascular Medicine 3.9k
  • Hematology 552
  • Rheumatology 524
  • Immunology 668
Replace Anetta Undas with:
Anetta Undas Poland
Anetta Undas Poland
Eduard Shantsila United Kingdom
Tobias Geisler Germany
Vanessa Roldán Spain
Ettore Porreca Italy
Pascale Gaussem France
Marina Camera Italy
Elvira Grandone Italy
Pierre Fontana Switzerland
Agneta Siegbahn relative to Anetta Undas Poland Anetta Undas's profile →
Citations per field
00.5×3.2×
Anetta Undas · 1×
Citations per year

Countries citing papers authored by Agneta Siegbahn

Since Specialization
Citations

This map shows the geographic impact of Agneta Siegbahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Siegbahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Siegbahn more than expected).

Fields of papers citing papers by Agneta Siegbahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta Siegbahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Siegbahn. The network helps show where Agneta Siegbahn may publish in the future.

Co-authors

The 25 scholars most cited alongside Agneta Siegbahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Agneta Siegbahn Line = papers co-authored together Agneta Siegbahn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20245
3 20236
4 20237
5 202229
6 202186
7 202120
8 20217
9 20216
10 20212
11 202129
12 20213
13 202066
14 202041
15 20205
16 20194
17
The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment
20141
18
Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome? : - A Report From the Plato Gwas Study
20132
19
Abstract 18321: D-dimer is Prognostic for Stroke, Major Bleeding and Death During Anticoagulation of Atrial Fibrillation - a RELY Substudy
20102
20 200938

About Agneta Siegbahn

Agneta Siegbahn is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Rheumatology and Immunology and Allergy, having authored 131 papers that have together received 6.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (45 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers), Acute Myocardial Infarction Research (21 papers), Venous Thromboembolism Diagnosis and Management (19 papers), GDF15 and Related Biomarkers (18 papers), Lipoproteins and Cardiovascular Health (14 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Cardiac Fibrosis and Remodeling (11 papers). The work is most often cited by research in Internal Medicine (1.2k citations), Cardiology and Cardiovascular Medicine (3.9k citations), Hematology (552 citations), Rheumatology (524 citations) and Immunology (668 citations). Agneta Siegbahn has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Lars Wallentin, Stefan James, Jonas Oldgren, Ziad Hijazi, Kenneth J. Winters, Claes Held, Christopher B. Granger, Joseph A. Jakubowski, John H. Alexander and Renato D. Lópes. Their work appears in journals such as European Heart Journal, Journal of the American Heart Association, Circulation, American Heart Journal and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026